Topical capsaicin 8% for the treatment of neuropathic itch conditions-Reference-Cited by-同舟云学术

Topical capsaicin 8% for the treatment of neuropathic itch conditions

Published:2017-05-29 Issue:5 Volume:42 Page:596-598
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Andersen H. H.¹,Arendt-Nielsen L.¹,Elberling J.²

Affiliation:

1. Laboratory of Cutaneous Experimental Pain Research, Department of Health Science and Technology; SMI, Faculty of Medicine; Aalborg University; Aalborg Denmark

2. Department of Dermato-Allergology; Copenhagen University Hospital; Herlev-Gentofte Hospital; Copenhagen Denmark

Funder

Uddannelses- og Forskningsministeriet

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.13114/fullpdf

Reference7 articles.

1. Therapy of pruritus;Patel;Expert Opin Pharmacother,2010

2. Common neuropathic itch syndromes;Oaklander;Acta Derm Venereol,2012

3. Considerable variability in the efficacy of 8% capsaicin topical patches in the treatment of chronic pruritus in 3 patients with notalgia paresthetica;Andersen;Ann Dermatol,2016

4. Successful treatment of refractory neuropathic pruritus with capsaicin 8% patch: a bicentric retrospective study with long-term follow-up;Misery;Acta Derm Venereol,2015

5. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch;Johanek;J Neurosci,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Intra-brainstem Circuit for Pain-induced Inhibition of Itch;2024-07-04

2. Current and emerging drugs for the treatment of pruritus: an update of the literature;Expert Opinion on Pharmacotherapy;2024-04-12

3. Neuropathischer Pruritus – evidenzbasierte Behandlungsempfehlungen;Der Nervenarzt;2022-08-11

4. Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects;Pharmaceuticals;2022-07-19

5. Scalp dysesthesia: a neuropathic phenomenon;Journal of the European Academy of Dermatology and Venereology;2022-02-14